Anteris Technologies Global (NASDAQ:AVR) Stock: Insider L1 Capital Pty Ltd Purchases 236,354 Shares

Anteris Technologies Global Corp. (NASDAQ:AVR) major shareholder L1 Capital Pty Ltd purchased 236,354 shares of the firm’s stock in a transaction dated Friday, October 2nd. The shares were bought at an average cost of $7.78 per share, for a total transaction of $1,838,834.12. Following the completion of the purchase, the insider directly owned 12,129,925 shares of the company’s stock, valued at $94,370,816.50. The trade was a 1.99% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Large shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

L1 Capital Pty Ltd also recently made the following trade(s):

• On Monday, October 5th, L1 Capital Pty Ltd purchased 648,455 shares of Anteris Technologies Global stock. The stock was bought at an average cost of $7.51 per share, with a total value of $4,869,897.05.
• On Thursday, October 1st, L1 Capital Pty Ltd acquired 322,940 shares of Anteris Technologies Global stock. The stock was bought at an average price of $7.60 per share, with a total value of $2,454,344.00.
• On Wednesday, September 30th, L1 Capital Pty Ltd acquired 74,286 shares of Anteris Technologies Global stock. The shares were purchased at an average cost of $7.72 per share, for a total transaction of $573,487.92.
• On Friday, August 28th, L1 Capital Pty Ltd sold 7,800 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.83, for a total value of $68,874.00.
• On Tuesday, August 11th, L1 Capital Pty Ltd sold 375,815 shares of Anteris Technologies Global stock. The shares were sold at an average price of $9.30, for a total value of $3,495,079.50.
• On Monday, August 10th, L1 Capital Pty Ltd sold 251,844 shares of Anteris Technologies Global stock. The shares were sold at an average price of $9.10, for a total value of $2,291,780.40.
• On Thursday, August 6th, L1 Capital Pty Ltd sold 174,721 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.10, for a total value of $1,415,240.10.
• On Tuesday, August 4th, L1 Capital Pty Ltd sold 480,608 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.30, for a total value of $3,989,046.40.
• On Wednesday, August 5th, L1 Capital Pty Ltd sold 14,581 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.23, for a total value of $120,001.63.
• On Monday, August 3rd, L1 Capital Pty Ltd sold 475,693 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.10, for a total value of $3,853,113.30.

Anteris Technologies Global Stock Down 3.3%

Shares of AVR stock opened at $6.82 on Thursday. The stock has a 50-day moving average price of $8.44 and a 200 day moving average price of $8.02. The firm has a market cap of $664.68 million, a price-to-earnings ratio of -3.50 and a beta of 1.87. Anteris Technologies Global Corp. has a 12 month low of $3.30 and a 12 month high of $11.06.

Anteris Technologies Global (NASDAQ:AVR) last announced its quarterly earnings data on Tuesday, August 11th. The company reported ($0.30) earnings per share for the quarter, missing the consensus estimate of ($0.21) by ($0.09). Anteris Technologies Global had a negative return on equity of 77.69% and a negative net margin of 4,619.27%.The firm had revenue of $1.01 million for the quarter, compared to the consensus estimate of $1.50 million. During the same period in the prior year, the firm posted ($0.58) earnings per share. Sell-side analysts predict that Anteris Technologies Global Corp. will post -1.21 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Anteris Technologies Global

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in AVR. Legal & General Group Plc acquired a new position in shares of Anteris Technologies Global during the 2nd quarter worth about $78,000. Abel Hall LLC acquired a new stake in shares of Anteris Technologies Global in the 1st quarter valued at approximately $63,000. Bartlett & CO. Wealth Management LLC raised its position in shares of Anteris Technologies Global by 174.5% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 12,900 shares of the company’s stock valued at $79,000 after acquiring an additional 8,200 shares during the period. One68 Global Capital LLC acquired a new stake in shares of Anteris Technologies Global in the 2nd quarter valued at approximately $128,000. Finally, J. Derek Lewis & Associates Inc. bought a new position in Anteris Technologies Global during the 4th quarter worth approximately $70,000.

Analyst Ratings Changes

Several equities analysts recently weighed in on the stock. Barclays began coverage on shares of Anteris Technologies Global in a report on Tuesday. They issued an “equal weight” rating and a $10.00 price objective on the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Anteris Technologies Global in a report on Wednesday, August 26th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $15.00 target price on shares of Anteris Technologies Global in a report on Friday, August 14th. Three research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Anteris Technologies Global presently has an average rating of “Hold” and a consensus price target of $14.00.

Anteris Technologies Global News Roundup

Here are the key news stories impacting Anteris Technologies Global this week:

• Positive Sentiment: Major shareholder made substantial purchases. L1 Capital Pty Ltd bought 648,455 AVR shares on October 5 at an average of $7.51, worth approximately $4.87 million, increasing its position by 5.35% to 12.78 million shares. The investor also purchased 236,354 shares on October 2 for about $1.84 million. The buying may bolster confidence because a large shareholder is committing additional capital while the stock is trading below recent moving averages. AVR insider buying report
• Neutral Sentiment: Share and incentive records were updated. Anteris reported a slight decrease in CHESS Depositary Interests and the lapse or cessation of several restricted stock unit and option tranches. These changes could affect the share count and potential dilution, but no new operating, clinical, or regulatory catalyst was announced. AVR CDI and equity incentive update
• Negative Sentiment: Financial performance remains weak. Anteris’ latest quarterly loss of $0.30 per share was wider than the $0.21 consensus estimate, while revenue of $1.01 million trailed expectations of $1.50 million. The clinical-stage structural-heart company remains unprofitable, with analysts expecting a full-year loss, factors that continue to weigh on valuation and investor sentiment. AVR earnings and performance report

About Anteris Technologies Global

Anteris Technologies Global is a clinical-stage structural heart company developing technologies intended to treat aortic valve disease. The company’s lead product is the DurAVR transcatheter heart valve, which is designed to replicate the performance characteristics of a healthy human aortic valve and restore more natural blood flow.

Anteris uses its proprietary ADAPT tissue-engineering technology to create heart-valve materials designed for durability and biocompatibility. The company is focused primarily on transcatheter aortic valve replacement and related structural-heart applications, with its products progressing through clinical development and regulatory evaluation rather than broad commercial distribution.

The company has Australian origins and maintains operations and clinical-development activities in both Australia and the United States.